{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:59:58Z","timestamp":1792439998258,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jid.2020.08.018","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T22:07:05Z","timestamp":1600207625000},"page":"883-893.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["QR-313, an Antisense Oligonucleotide, Shows\u00a0Therapeutic Efficacy for Treatment of\u00a0Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-0242","authenticated-orcid":false,"given":"Olivier","family":"Bornert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-9114","authenticated-orcid":false,"given":"Marieke","family":"Hogervorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-2339","authenticated-orcid":false,"given":"Pauline","family":"Nauroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5309-1936","authenticated-orcid":false,"given":"Johannes","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7793-8580","authenticated-orcid":false,"given":"Jim","family":"Swildens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5158-673X","authenticated-orcid":false,"given":"Ioannis","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-8041","authenticated-orcid":false,"given":"Sara F.","family":"Tufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-370X","authenticated-orcid":false,"given":"Douglas R.","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2331-8981","authenticated-orcid":false,"given":"Dimitra","family":"Kiritsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-0039","authenticated-orcid":false,"given":"Stefan","family":"Hainzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5237-3632","authenticated-orcid":false,"given":"Eva M.","family":"Murauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-8046","authenticated-orcid":false,"given":"M. Peter","family":"Marinkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3499-7542","authenticated-orcid":false,"given":"Gerard","family":"Platenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-4962","authenticated-orcid":false,"given":"Ingrid","family":"Hausser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-3890","authenticated-orcid":false,"given":"Verena","family":"Wally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2770-5305","authenticated-orcid":false,"given":"Tita","family":"Ritsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-1789","authenticated-orcid":false,"given":"Ulrich","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9759-900X","authenticated-orcid":false,"given":"Elisabeth M.","family":"Haisma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-2240","authenticated-orcid":false,"given":"Alexander","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.08.018_bib1","first-page":"163","article-title":"Skin models for the testing of transdermal drugs","volume":"8","author":"Abd","year":"2016","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.jid.2020.08.018_bib2","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1016\/S0021-9258(19)38784-8","article-title":"The relationship of the biophysical and biochemical characteristics of type VII collagen to the function of anchoring fibrils","volume":"265","author":"B\u00e4chinger","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2020.08.018_bib3","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/mt.2016.92","article-title":"Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy","volume":"24","author":"Bornert","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2020.08.018_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-9095-5_1","article-title":"Cloning and mutagenesis strategies for large collagens","volume":"1944","author":"Bornert","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jid.2020.08.018_bib4","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1038\/mtna.2016.87","article-title":"Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa","volume":"5","author":"Bremer","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jid.2020.08.018_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.omtn.2019.09.009","article-title":"Natural exon skipping sets the stage for exon skipping as therapy for dystrophic epidermolysis bullosa","volume":"18","author":"Bremer","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jid.2020.08.018_bib6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/exd.13744","article-title":"Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa","volume":"28","author":"Bremer","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/idoj.IDOJ_287_18","article-title":"Newer treatment modalities in epidermolysis bullosa","volume":"10","author":"Bruckner-Tuderman","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jid.2020.08.018_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aas9668","article-title":"APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","volume":"10","author":"Cho","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2020.08.018_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-2008-1063444","article-title":"Current concepts in pediatric burn care: the biology of cultured epithelial autografts: an eight-year study in pediatric burn patients","volume":"2","author":"Compton","year":"1992","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.jid.2020.08.018_bib11","doi-asserted-by":"crossref","first-page":"e130554","DOI":"10.1172\/jci.insight.130554","article-title":"Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa","volume":"4","author":"Eichstadt","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2020.08.018_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1750-1172-9-76","article-title":"Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa","volume":"9","author":"El Hachem","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2020.08.018_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-5-12","article-title":"Inherited epidermolysis bullosa","volume":"5","author":"Fine","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2020.08.018_bib14","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","article-title":"Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry","volume":"152","author":"Fine","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.11.004","article-title":"Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas","volume":"66","author":"F\u00f6ll","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2020.08.018_bib16","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A\u00a0hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.08.018_bib17","doi-asserted-by":"crossref","first-page":"30248","DOI":"10.1074\/jbc.M109.045294","article-title":"Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII","volume":"284","author":"Fritsch","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2020.08.018_bib18","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/sj.jid.5700435","article-title":"Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients","volume":"126","author":"Goto","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1083\/jcb.104.3.611","article-title":"Type VII collagen forms an extended network of anchoring fibrils","volume":"104","author":"Keene","year":"1987","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jid.2020.08.018_bib20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2020.08.018_bib21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jid.2016.02.002","article-title":"Collagen VII half-life at the dermal-epidermal junction zone: implications for mechanisms and therapy of genodermatoses","volume":"136","author":"K\u00fchl","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa","volume":"23","author":"K\u00fchl","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2020.08.018_bib23","doi-asserted-by":"crossref","first-page":"e126243","DOI":"10.1172\/jci.insight.126243","article-title":"Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa","volume":"4","author":"Lwin","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2020.08.018_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/aja.1001970404","article-title":"Cellular origin of the dermal-epidermal basement membrane","volume":"197","author":"Marinkovich","year":"1993","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jid.2020.08.018_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1523-1747.1999.00518.x","article-title":"Clustering of COL7A1 mutations in exon 73: implications for mutation analysis in dystrophic epidermolysis bullosa","volume":"112","author":"Mecklenbeck","year":"1999","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.matbio.2018.01.016","article-title":"Injury- and inflammation-driven skin fibrosis: the paradigm of epidermolysis bullosa","volume":"68\u201369","author":"Nystr\u00f6m","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2020.08.018_bib27","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI68127","article-title":"Collagen VII plays a dual role in wound healing","volume":"123","author":"Nystr\u00f6m","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.08.018_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bjd.13945","article-title":"A\u00a0COL7A1 variant leading to in-frame skipping of exon 15 attenuates disease severity in recessive dystrophic epidermolysis bullosa","volume":"173","author":"Schwieger-Briel","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib29","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2020.08.018_bib37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ebiom.2019.04.062","article-title":"Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders","volume":"44","author":"Sp\u00f6rrer","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jid.2020.08.018_bib30","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","article-title":"Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in\u00a0vivo RDEB model","volume":"136","author":"Turczynski","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/bjd.17943","article-title":"Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa","volume":"181","author":"Twaroski","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2020.08.018_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jmg.2006.045302","article-title":"Epidermolysis bullosa. II. type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes","volume":"44","author":"Varki","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2020.08.018_bib33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/mt.2013.87","article-title":"Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure","volume":"21","author":"Wang","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2020.08.018_bib34","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1074\/jbc.M709452200","article-title":"Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis","volume":"283","author":"Woodley","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2020.08.018_bib35","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/hmg\/ddx110","article-title":"P4HA1 mutations cause a unique congenital disorder of connective tissue involving tendon, bone, muscle and the eye","volume":"26","author":"Zou","year":"2017","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20320613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20320613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:20:38Z","timestamp":1758302438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20320613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0022202X20320613"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.08.018","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QR-313, an Antisense Oligonucleotide, Shows\u00a0Therapeutic Efficacy for Treatment of\u00a0Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}